Smartleaf Asset Management’s Fennec Pharmaceuticals FENC Stock Holding History

Smartleaf Asset Management’s Portfolio FENC Stock Details FENC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.19K	Hold	110	–	–	﹤0.01%	3160
2026 Q2	$1.21K	Hold	110	–	–	﹤0.01%	3067
2026 Q1	$635	Hold	110	–	–	﹤0.01%	3186
2025 Q4	$854	Hold	110	–	–	﹤0.01%	3182
2025 Q3	$999	Hold	110	–	–	﹤0.01%	2750
2025 Q2	$907	Hold	110	–	–	﹤0.01%	2493
2025 Q1	$715	Hold	110	–	–	﹤0.01%	2639
2024 Q4	$677	Buy	+110	New	+$563	﹤0.01%	2736

Other funds holding FENC

ACM

AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

AIC

AWM Investment Company New York $1.04B AUM 103.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Essex Investment Management Boston, Massachusetts $675M AUM 61.81% 1-Year Est. Return

CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Smartleaf Asset Management's FENC Position: Q3 2026 in Review

Smartleaf Asset Management held its Fennec Pharmaceuticals (FENC) position steady in Q3 2026 at 110 shares worth $1.19K. The position accounts for ﹤0.01% of the portfolio, ranked #3160.

Smartleaf Asset Management first reported a position in FENC in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.21K in Q2 2026. 80 funds tracked by Wall St. Rank hold FENC as of Q3 2026.

Smartleaf Asset Management held 110 shares of Fennec Pharmaceuticals worth $1.19K as of Q3 2026.
Smartleaf Asset Management left its Fennec Pharmaceuticals share count unchanged in Q3 2026.
Fennec Pharmaceuticals made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q3 2026, its #3160 holding.
Smartleaf Asset Management first reported a position in Fennec Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
Smartleaf Asset Management's Fennec Pharmaceuticals position peaked at $1.21K in Q2 2026.
80 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2026.

Based on Smartleaf Asset Management's 13F filing for Q3 2026, filed 10 Nov 2026.